vs

Side-by-side financial comparison of ACACIA RESEARCH CORP (ACTG) and VIEMED HEALTHCARE, INC. (VMD). Click either name above to swap in a different company.

VIEMED HEALTHCARE, INC. is the larger business by last-quarter revenue ($76.2M vs $50.1M, roughly 1.5× ACACIA RESEARCH CORP). VIEMED HEALTHCARE, INC. runs the higher net margin — 7.4% vs 6.8%, a 0.6% gap on every dollar of revenue. On growth, VIEMED HEALTHCARE, INC. posted the faster year-over-year revenue change (25.5% vs 2.6%). Over the past eight quarters, ACACIA RESEARCH CORP's revenue compounded faster (43.6% CAGR vs 22.7%).

Acacia Research Corporation is a publicly traded American company based in New York City. It acquires and operates businesses in industries including the technology, energy, and industrial/manufacturing sectors. Acacia has a strategic relationship with Starboard Value, LP, the company's controlling shareholder. The company has been characterized as a patent troll.

Viemed Healthcare, Inc. is a medical technology firm specializing in respiratory care solutions. It develops, manufactures and distributes portable ventilators, respiratory therapy devices and related support services, catering to acute care, post-acute care and home care segments across North America, Europe and key Asia-Pacific markets for patients with respiratory conditions.

ACTG vs VMD — Head-to-Head

Bigger by revenue
VMD
VMD
1.5× larger
VMD
$76.2M
$50.1M
ACTG
Growing faster (revenue YoY)
VMD
VMD
+22.9% gap
VMD
25.5%
2.6%
ACTG
Higher net margin
VMD
VMD
0.6% more per $
VMD
7.4%
6.8%
ACTG
Faster 2-yr revenue CAGR
ACTG
ACTG
Annualised
ACTG
43.6%
22.7%
VMD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ACTG
ACTG
VMD
VMD
Revenue
$50.1M
$76.2M
Net Profit
$3.4M
$5.6M
Gross Margin
12.8%
57.9%
Operating Margin
-26.1%
11.0%
Net Margin
6.8%
7.4%
Revenue YoY
2.6%
25.5%
Net Profit YoY
125.5%
30.7%
EPS (diluted)
$0.03
$0.14

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACTG
ACTG
VMD
VMD
Q4 25
$50.1M
$76.2M
Q3 25
$59.4M
$71.9M
Q2 25
$51.2M
$63.1M
Q1 25
$124.4M
$59.1M
Q4 24
$48.8M
$60.7M
Q3 24
$23.3M
$58.0M
Q2 24
$25.8M
$55.0M
Q1 24
$24.3M
$50.6M
Net Profit
ACTG
ACTG
VMD
VMD
Q4 25
$3.4M
$5.6M
Q3 25
$-2.7M
$3.5M
Q2 25
$-3.3M
$3.2M
Q1 25
$24.3M
$2.6M
Q4 24
$-13.4M
$4.3M
Q3 24
$-14.0M
$3.9M
Q2 24
$-8.4M
$1.5M
Q1 24
$-186.0K
$1.6M
Gross Margin
ACTG
ACTG
VMD
VMD
Q4 25
12.8%
57.9%
Q3 25
21.2%
57.5%
Q2 25
12.8%
58.3%
Q1 25
47.4%
56.3%
Q4 24
17.6%
59.5%
Q3 24
10.1%
59.3%
Q2 24
26.2%
59.8%
Q1 24
49.2%
58.9%
Operating Margin
ACTG
ACTG
VMD
VMD
Q4 25
-26.1%
11.0%
Q3 25
-10.8%
7.8%
Q2 25
-24.2%
8.1%
Q1 25
30.8%
6.5%
Q4 24
-32.4%
10.6%
Q3 24
-44.1%
9.7%
Q2 24
-18.4%
6.6%
Q1 24
-8.6%
4.4%
Net Margin
ACTG
ACTG
VMD
VMD
Q4 25
6.8%
7.4%
Q3 25
-4.6%
4.9%
Q2 25
-6.4%
5.0%
Q1 25
19.5%
4.4%
Q4 24
-27.5%
7.1%
Q3 24
-60.0%
6.7%
Q2 24
-32.7%
2.7%
Q1 24
-0.8%
3.2%
EPS (diluted)
ACTG
ACTG
VMD
VMD
Q4 25
$0.03
$0.14
Q3 25
$-0.03
$0.09
Q2 25
$-0.03
$0.08
Q1 25
$0.25
$0.06
Q4 24
$-0.14
$0.10
Q3 24
$-0.14
$0.10
Q2 24
$-0.08
$0.04
Q1 24
$0.00
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACTG
ACTG
VMD
VMD
Cash + ST InvestmentsLiquidity on hand
$306.7M
$13.5M
Total DebtLower is stronger
$91.9M
Stockholders' EquityBook value
$543.5M
$141.5M
Total Assets
$771.0M
$199.2M
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACTG
ACTG
VMD
VMD
Q4 25
$306.7M
$13.5M
Q3 25
$301.8M
$11.1M
Q2 25
$316.7M
$20.0M
Q1 25
$272.0M
$10.2M
Q4 24
$273.9M
$17.5M
Q3 24
$410.9M
$11.3M
Q2 24
$441.9M
$8.8M
Q1 24
$498.4M
$7.3M
Total Debt
ACTG
ACTG
VMD
VMD
Q4 25
$91.9M
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ACTG
ACTG
VMD
VMD
Q4 25
$543.5M
$141.5M
Q3 25
$537.6M
$133.6M
Q2 25
$538.6M
$139.7M
Q1 25
$540.2M
$134.8M
Q4 24
$514.8M
$131.4M
Q3 24
$540.2M
$125.0M
Q2 24
$560.7M
$119.4M
Q1 24
$568.3M
$116.3M
Total Assets
ACTG
ACTG
VMD
VMD
Q4 25
$771.0M
$199.2M
Q3 25
$768.9M
$202.4M
Q2 25
$775.5M
$184.6M
Q1 25
$801.6M
$178.1M
Q4 24
$756.4M
$177.1M
Q3 24
$707.6M
$169.5M
Q2 24
$753.6M
$163.9M
Q1 24
$631.7M
$154.9M
Debt / Equity
ACTG
ACTG
VMD
VMD
Q4 25
0.17×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACTG
ACTG
VMD
VMD
Operating Cash FlowLast quarter
$75.2M
$18.4M
Free Cash FlowOCF − Capex
$9.7M
FCF MarginFCF / Revenue
12.7%
Capex IntensityCapex / Revenue
11.5%
Cash ConversionOCF / Net Profit
22.01×
3.27×
TTM Free Cash FlowTrailing 4 quarters
$11.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACTG
ACTG
VMD
VMD
Q4 25
$75.2M
$18.4M
Q3 25
$9.5M
$18.4M
Q2 25
$50.1M
$12.3M
Q1 25
$2.4M
$2.9M
Q4 24
$50.1M
$15.0M
Q3 24
$-593.0K
$12.7M
Q2 24
$16.1M
$10.2M
Q1 24
$54.8M
$1.2M
Free Cash Flow
ACTG
ACTG
VMD
VMD
Q4 25
$9.7M
Q3 25
$10.7M
Q2 25
$4.1M
Q1 25
$335.0K
$-12.6M
Q4 24
$-98.5M
$3.2M
Q3 24
$-2.8M
$1.7M
Q2 24
$-126.7M
$1.2M
Q1 24
$54.6M
$-4.8M
FCF Margin
ACTG
ACTG
VMD
VMD
Q4 25
12.7%
Q3 25
14.9%
Q2 25
6.5%
Q1 25
0.3%
-21.4%
Q4 24
-201.8%
5.2%
Q3 24
-12.1%
3.0%
Q2 24
-490.5%
2.3%
Q1 24
224.4%
-9.5%
Capex Intensity
ACTG
ACTG
VMD
VMD
Q4 25
11.5%
Q3 25
10.6%
Q2 25
12.9%
Q1 25
1.7%
26.2%
Q4 24
304.4%
19.5%
Q3 24
9.6%
19.0%
Q2 24
553.0%
16.3%
Q1 24
1.1%
11.9%
Cash Conversion
ACTG
ACTG
VMD
VMD
Q4 25
22.01×
3.27×
Q3 25
5.23×
Q2 25
3.88×
Q1 25
0.10×
1.09×
Q4 24
3.47×
Q3 24
3.29×
Q2 24
6.94×
Q1 24
0.73×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACTG
ACTG

Energy Operations$16.0M32%
Transportation Safety$10.4M21%
Office Storage And Display Solutions$8.4M17%
Printers Consumables And Parts$6.5M13%
Natural Gas Reserves$5.1M10%
Natural Gas Liquids Reserves$3.3M7%

VMD
VMD

Segment breakdown not available.

Related Comparisons